These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 25605794)

  • 1. Molecular mechanisms in DM1 - a focus on foci.
    Pettersson OJ; Aagaard L; Jensen TG; Damgaard CK
    Nucleic Acids Res; 2015 Feb; 43(4):2433-41. PubMed ID: 25605794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DDX6 regulates sequestered nuclear CUG-expanded DMPK-mRNA in dystrophia myotonica type 1.
    Pettersson OJ; Aagaard L; Andrejeva D; Thomsen R; Jensen TG; Damgaard CK
    Nucleic Acids Res; 2014 Jun; 42(11):7186-200. PubMed ID: 24792155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoplasmic CUG RNA foci are insufficient to elicit key DM1 features.
    Dansithong W; Wolf CM; Sarkar P; Paul S; Chiang A; Holt I; Morris GE; Branco D; Sherwood MC; Comai L; Berul CI; Reddy S
    PLoS One; 2008; 3(12):e3968. PubMed ID: 19092997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sense and Antisense DMPK RNA Foci Accumulate in DM1 Tissues during Development.
    Michel L; Huguet-Lachon A; Gourdon G
    PLoS One; 2015; 10(9):e0137620. PubMed ID: 26339785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy.
    Ho TH; Savkur RS; Poulos MG; Mancini MA; Swanson MS; Cooper TA
    J Cell Sci; 2005 Jul; 118(Pt 13):2923-33. PubMed ID: 15961406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1.
    de Haro M; Al-Ramahi I; De Gouyon B; Ukani L; Rosa A; Faustino NA; Ashizawa T; Cooper TA; Botas J
    Hum Mol Genet; 2006 Jul; 15(13):2138-45. PubMed ID: 16723374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput kinome-RNAi screen identifies protein kinase R activator (PACT) as a novel genetic modifier of CUG foci integrity in myotonic dystrophy type 1 (DM1).
    Neault N; O'Reilly S; Baig AT; Plaza-Diaz J; Azimi M; Farooq F; Baird SD; MacKenzie A
    PLoS One; 2021; 16(9):e0256276. PubMed ID: 34520479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic therapy in an RNA toxicity mouse model with an antisense oligonucleotide therapy targeting a non-CUG sequence within the DMPK 3'UTR RNA.
    Yadava RS; Yu Q; Mandal M; Rigo F; Bennett CF; Mahadevan MS
    Hum Mol Genet; 2020 Jun; 29(9):1440-1453. PubMed ID: 32242217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hammerhead ribozyme-mediated destruction of nuclear foci in myotonic dystrophy myoblasts.
    Langlois MA; Lee NS; Rossi JJ; Puymirat J
    Mol Ther; 2003 May; 7(5 Pt 1):670-80. PubMed ID: 12718910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of MBNL1-mediated retrograde BDNF signaling in the myotonic dystrophy brain.
    Wang PY; Kuo TY; Wang LH; Liang WH; Wang GS
    Acta Neuropathol Commun; 2023 Mar; 11(1):44. PubMed ID: 36922901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy.
    Wang GS; Kearney DL; De Biasi M; Taffet G; Cooper TA
    J Clin Invest; 2007 Oct; 117(10):2802-11. PubMed ID: 17823658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Furamidine Rescues Myotonic Dystrophy Type I Associated Mis-Splicing through Multiple Mechanisms.
    Jenquin JR; Coonrod LA; Silverglate QA; Pellitier NA; Hale MA; Xia G; Nakamori M; Berglund JA
    ACS Chem Biol; 2018 Sep; 13(9):2708-2718. PubMed ID: 30118588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced cytoplasmic MBNL1 is an early event in a brain-specific mouse model of myotonic dystrophy.
    Wang PY; Lin YM; Wang LH; Kuo TY; Cheng SJ; Wang GS
    Hum Mol Genet; 2017 Jun; 26(12):2247-2257. PubMed ID: 28369378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CTG repeat expansion size correlates with the splicing defects observed in muscles from myotonic dystrophy type 1 patients.
    Botta A; Rinaldi F; Catalli C; Vergani L; Bonifazi E; Romeo V; Loro E; Viola A; Angelini C; Novelli G
    J Med Genet; 2008 Oct; 45(10):639-46. PubMed ID: 18611984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HnRNP H inhibits nuclear export of mRNA containing expanded CUG repeats and a distal branch point sequence.
    Kim DH; Langlois MA; Lee KB; Riggs AD; Puymirat J; Rossi JJ
    Nucleic Acids Res; 2005; 33(12):3866-74. PubMed ID: 16027111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fuchs' Endothelial Corneal Dystrophy and RNA Foci in Patients With Myotonic Dystrophy.
    Mootha VV; Hansen B; Rong Z; Mammen PP; Zhou Z; Xing C; Gong X
    Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4579-4585. PubMed ID: 28886202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hallmarks of myotonic dystrophy type 1 muscle dysfunction.
    Ozimski LL; Sabater-Arcis M; Bargiela A; Artero R
    Biol Rev Camb Philos Soc; 2021 Apr; 96(2):716-730. PubMed ID: 33269537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2.
    Mankodi A; Urbinati CR; Yuan QP; Moxley RT; Sansone V; Krym M; Henderson D; Schalling M; Swanson MS; Thornton CA
    Hum Mol Genet; 2001 Sep; 10(19):2165-70. PubMed ID: 11590133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts.
    Fardaei M; Larkin K; Brook JD; Hamshere MG
    Nucleic Acids Res; 2001 Jul; 29(13):2766-71. PubMed ID: 11433021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic delivery of a Peptide-linked morpholino oligonucleotide neutralizes mutant RNA toxicity in a mouse model of myotonic dystrophy.
    Leger AJ; Mosquea LM; Clayton NP; Wu IH; Weeden T; Nelson CA; Phillips L; Roberts E; Piepenhagen PA; Cheng SH; Wentworth BM
    Nucleic Acid Ther; 2013 Apr; 23(2):109-17. PubMed ID: 23308382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.